UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 171

Sortiert nach

Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors

Stem cells (Dayton, Ohio), 2011-06, Vol.29 (6), p.913-919

2011

Link zum Volltext

Verfügbarkeit prüfen

Actin‐binding protein filamin A is displayed on the surface of human neuroblastoma cells

Cancer science, 2006-12, Vol.97 (12), p.1359-1365

2006

Link zum Volltext

Verfügbarkeit prüfen

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

Gynecologic oncology, 2015-10, Vol.139 (1), p.17-22

2015

Link zum Volltext

Verfügbarkeit prüfen

Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties

International journal of radiation oncology, biology, physics, 2021-06, Vol.110 (2), p.322-327

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2

Journal of clinical oncology, 2017-12, Vol.35 (35), p.3942-3948

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial

JAMA oncology, 2021-03, Vol.7 (3), p.421

2021

Link zum Volltext

Verfügbarkeit prüfen

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

The New England journal of medicine, 2023-04, Vol.388 (17), p.1547-1558

2023

Link zum Volltext

Verfügbarkeit prüfen

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer

Journal of clinical oncology, 2017-10, Vol.35 (30), p.3391-3400

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer

PloS one, 2013-03, Vol.8 (3), p.e54014

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

Journal of clinical oncology, 2016-07, Vol.34 (20), p.2325-2332

2016

Link zum Volltext

Verfügbarkeit prüfen

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study

The lancet oncology, 2018-04, Vol.19 (4), p.486-496

2018

Link zum Volltext

Verfügbarkeit prüfen

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

The New England journal of medicine, 2017-02, Vol.376 (5), p.417-428

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT

Annals of nuclear medicine, 2017-10, Vol.31 (8), p.623-628

2017

Link zum Volltext

Verfügbarkeit prüfen

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

Journal of immunotherapy (1997), 2019-05, Vol.42 (4), p.126

2019

Link zum Volltext

Verfügbarkeit prüfen

Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery

Journal of thoracic oncology, 2024-03, Vol.19 (3), p.476-490

2024

Link zum Volltext

Verfügbarkeit prüfen

FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer

Breast cancer research : BCR, 2023-08, Vol.25 (1), p.99-99, Article 99

2023

Link zum Volltext

Verfügbarkeit prüfen

Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3232-3239

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas

Clinical cancer research, 2022-01, Vol.28 (2), p.279-288

2022

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials

The lancet oncology, 2018-03, Vol.19 (3), p.416-426

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 171

Suche als RSS-Feed

Aktive Filter

ThemaCancer Research

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164)
Mit Volltextzugriff
(151)

Publikationsform

Artikel
(171)

Sprache

Englisch
(171)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(166)
Life Sciences & Biomedicine
(165)
Humans
(142)
Female
(89)
Male
(79)
Middle Aged
(77)
Aged
(72)
Adult
(64)
Biological And Medical Sciences
(63)
Medical Sciences
(63)
Tumors
(39)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(33)
Pharmacology. Drug Treatments
(31)
Chemotherapy
(30)
Aged, 80 And Over
(29)
Antineoplastic Agents
(28)
Prognosis
(24)
Treatment Outcome
(24)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(23)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors

Actin‐binding protein filamin A is displayed on the surface of human neuroblastoma cells

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other Specialties

Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer

Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study

Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery

FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer

Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study

Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas

Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial

Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials

Aktive Filter

Suchergebnisse filtern